Scale, adapt with our FDA and government contracting services.
DELIVERY SOLUTION WITH STS CORPORATION
Innovative Global Expansion within Reach
MISSION STATMENT
Creating new streams of revenue through Government and Commercial channels for domestic and international corporations
Excellence is our legacy. Our quest to be the very best has brought us here and has allowed us to move America forward. We strive for excellence in everything that we do from supply chain management to FDA regulatory listings to government contracting services. Our international reach and active distribution channels allow us to provide world class service paired with unmatched results for our clients.
OUR SERVICES
Our experienced team identifies government contract opportunities through various mediums to open up a new source of revenue for our clients. The government contracts STS Corporation specializes in can contribute to a number of growth factors: increase in revenue, expanding market share, building innovative infrastructure, and more.
FDA Regulatory Services
STS Corporation (STSC) Drug Development and Regulatory Department provides the best pathway for companies and their products through every stage when pursuing FDA approvals. Services provided by STS Corporation for Medical Device Submission Service and Registration include:
-
Product establishment registration and Listing
-
510(k) Premarket Notification
-
FDA Over-the-Counter Services
-
Other's
Government Services
The STSC team has a systematic infrastructure that has produced results for the past 20 years, obtaining millions of government funding for our clients who have sold their services to the federal, state, and local governments to share the company history or highlight a particular feature that sets it apart from competitors.
Rest assured that no matter what you need, you can rely on us to provide the absolute best. Weather pursuing a Government and FDA Compliance.
PROJECTS
A Different Approach, For Scaling Your Business
AI-Powered Nanotechnology for Multi-Cancer Liquid Biopsy
EXoPERT is revolutionizing early cancer detection through a first-in-class EV-SERS-AI platform. By combining high-purity exosome isolation with sensitive molecular "fingerprint" analysis, our technology enables accurate, non-invasive screening for multiple cancers from a single blood draw
Exo-i™ Kit
EV Isolation
Achieves >90% reduction of contaminants with high yield (≥1010 particles/mL).
ExoTractor™
Automated Isolation
Uses machine vision for standardized, high-throughput SEC-based isolation.+1
ARM DX™
Signal Detection
Automated Raman spectroscopy system providing high-throughput, standardized spectral acquisition.+1
ExoPred™
AI Classification
Proprietary algorithms that identify cancer molecular signatures with high diagnostic accuracy.+1
CORE TECHNOLOGY & PERFORMANCE
Precision Diagnostics Through Molecular Fingerprinting
Our platform utilizes Surface-Enhanced Raman Scattering (SERS) to amplify the Raman signal of biomolecules found on plasma-derived exosomes. This creates a unique "molecular fingerprint" that our AI software analyzes to detect cancer features with exceptional sensitivity
Proven Clinical Accuracy
Recent clinical trials and research studies (2023–2024) have demonstrated the platform's high diagnostic performance across various stages: +2
Pancreatic Cancer: Achieved an AUC of 0.925 for Stages III-IV and 0.798 for early Stages I-II.
Lung Cancer: Demonstrated an AUC of 0.904 for Stages III-IV and 0.831 for early Stages I-II.
Multi-Cancer Study: A study published in Nature Communications (2023) showed a combined 96.3% specificityand 89.4% sensitivity for six early-stage cancer types.
Applications & Future Pipeline
Beyond Oncology: A Disease-Agnostic EV Platform
While our primary focus is the Multi-Cancer Early Detection (MCED) market, the EXoPERT platform is inherently scalable to any disease with exosome biomarkers.
Multi-Cancer Screening: Targeting high-risk adults and the general population for early detection of lung, breast, colorectal, pancreatic, and liver cancers.
Neurological Disorders: On-going R&D for depression diagnosis and identifying biomarkers for Alzheimer’s and Parkinson’s through EVs that cross the blood-brain barrier.
Prenatal Health: Improving the accuracy of fetal disease detection by monitoring EVs that cross the amniotic membrane. +1
Regenerative Medicine: Automated EV isolation for point-of-care therapeutic and pharmaceutical applications. +1
COLLABORATION
Our Industry Partners
13+
$40M
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Our experts have been helping corporation open new government and private sector
We specialize in Medical Devices, Pharmaceuticals, Raw Materials, R&D, and more.
From winning public government contracts to brokering deals between corporations, STSC continues to win and facilitate contracts daily.
10+
LATEST
PROJECTS
Nephron Nitrile Glove
Factory
Diatrust Distributionship
COMING
Soon